AQP4 and neuromyelitis optica: This antibody can be found in up to 30% of NMO patients who tested negative to AQP4-IgG.16However, the clinical and MRI findings of MOG-associated disease (MOGAD) goes beyond the NMOSD phenotype, expanding the new concept of MOGAD.17